Shoddy biopsies deny cancer patients a shot at personalized treatment

Elie Dolgin • January 22, 2016

A huge federal trial of personalized cancer medicine has run into an unexpected roadblock: Many of the tumor samples aren’t robust enough to be put through genetic analysis.

Continue reading at STAT.

By Elie Dolgin June 11, 2026
Enhanced cryo–electron microscopy promises to bring previously elusive proteins into view.
By Elie Dolgin April 30, 2026
AI-guided redesign of protein alphabet in bacteria could unlock new ways to build synthetic organisms.